The National Autonomous University of Mexico is a public research university in Mexico. It ranks highly in world rankings based on the university's extensive research and innovation. It is the largest university in Latin America and has one of the biggest campuses in the world.

During the past decade, Universidad Nacional Autónoma de México conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidad Nacional Autónoma de México" #1 collaborator was "Harvard Medical School (HMS and HSDM)" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universidad Nacional Autónoma de México" are "Healthy Subjects" (2 trials), "Intranasal Administration" (2 trials), "Dexamethasone Administration" (1 trials), "Food Labeling" (1 trials) and "Generalized Anxiety Disorder" (1 trials). Many other conditions were trialed in "Universidad Nacional Autónoma de México" in a lesser frequency.

Most popular intervention types in "Universidad Nacional Autónoma de México" are "Behavioral" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (1 trials), "Evaluation of bioavailability of methylprednisolone succinate administered intranasally" (1 trials), "Evaluation of bioavailability of methylprednisolone succinate administered intravenously" (1 trials), "Guideline Daily Amounts" (1 trials) and "Multiple Traffic Light" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidad Nacional Autónoma de México" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universidad Nacional Autónoma de México". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universidad Nacional Autónoma de México, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidad Nacional Autónoma de México, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Universidad Nacional Autónoma de México has several departments that took part in Clinical trials: "Faculty of Higher Studies Iztacala, National Autonomous University of Mexico" - 2 trials, "Instituto Nacional de Cardiologia Dr Ignacio Chavez Rivera" - 2 trials